Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:553-559

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toft, I.
Right arrow Articles by Jenssen, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toft, I.
Right arrow Articles by Jenssen, T.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:553-559.)
© 1997 American Heart Association, Inc.


Articles

Gender Differences in the Relationships Between Plasma Plasminogen Activator Inhibitor-1 Activity and Factors Linked to the Insulin Resistance Syndrome in Essential Hypertension

Ingrid Toft; Kaare H. Bønaa; Ole C. Ingebretsen; Arne Nordøy; Kåre I. Birkeland; ; Trond Jenssen

From the Institutes of Clinical Medicine (I.T.), Community Medicine (K.H.B.), and Medical Biology (O.C.I.), University of Tromsø; the Department of Internal Medicine, Tromsø University Hospital (A.N., T.J.); and the Department of Clinical Chemistry, Aker Hospital, Oslo (K.I.B.), Norway.

Abstract Impaired fibrinolysis due to elevated levels of plasma plasminogen activator inhibitor type 1 (PAI-1) is a risk factor for thromboembolic disease. Hypertension, obesity, derangements in lipid and glucose homeostasis, and elevated levels of PAI-1 are features of the insulin resistance syndrome. The interrelationships between PAI-1 and the metabolic disturbances seen in this condition are unsettled. We investigated the associations between PAI-1 activity and components of the insulin resistance syndrome in 53 men and 31 women with untreated hypertension. In men, PAI-1 activity correlated significantly with plasma glucose (r=.41, P=.002), insulin sensitivity (r=-.35, P=.01), and insulin-induced suppression of nonesterified fatty acid (NEFA) (r=-.43, P=.007). Plasma glucose and NEFA suppression were independently associated with PAI-1 activity in a multivariate analysis. In women, PAI-1 activity correlated with body mass index (r=.62, P=.0005), waist-to-hip ratio (r=.75, P=.0001), plasma glucose (r=.50, P=.007), insulin (r=.49, P=.009), proinsulin (r=.57, P=.002), C-peptide (r=.60, P=.0009), insulin sensitivity (r=-.74, P=.0001), NEFA suppression (r=-.64, P=.003), and triglycerides (r=.58, P=.001). In multivariate analyses, insulin sensitivity and NEFA suppression were independently associated with PAI-1 if waist-to-hip ratio was not included in the model. After introduction of waist-to-hip ratio into the model, waist-to-hip ratio was the only independent predictor of PAI-1 activity. We conclude that in women, waist-to-hip ratio, body mass index, and insulin-induced NEFA suppression are determinants for PAI-1 activity. In men, insulin-induced NEFA suppression and plasma glucose are independently associated with PAI-1 activity.


Key Words: hypertension • plasminogen activator inhibitor-1 • insulin action • waist-to-hip ratio




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. M. Bard, M. A. Charles, I. Juhan-Vague, P. Vague, P. Andre, M. Safar, J. C. Fruchart, E. Eschwege, and o. b. o. t. BIGPRO Study Group
Accumulation of Triglyceride-Rich Lipoprotein in Subjects With Abdominal Obesity : The Biguanides and the Prevention of the Risk of Obesity (BIGPRO) 1 Study
Arterioscler Thromb Vasc Biol, March 1, 2001; 21(3): 407 - 414.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
T. G. M. Vrijkotte, L. J. P. van Doornen, and E. J. C. de Geus
Work Stress and Metabolic and Hemostatic Risk Factors
Psychosom Med, November 1, 1999; 61(6): 796 - 805.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Abbasi, T. McLaughlin, C. Lamendola, I. Lipinska, G. Tofler, and G. M. Reaven
Comparison of Plasminogen Activator Inhibitor-1 Concentration in Insulin-Resistant Versus Insulin-Sensitive Healthy Women
Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2818 - 2821.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. J. Giltay, J. M. H. Elbers, L. J. G. Gooren, J. J. Emeis, T. Kooistra, H. Asscheman, and C. D. A. Stehouwer
Visceral Fat Accumulation Is an Important Determinant of PAI-1 Levels in Young, Nonobese Men and Women : Modulation by Cross-Sex Hormone Administration
Arterioscler Thromb Vasc Biol, November 1, 1998; 18(11): 1716 - 1722.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Byberg, A. Siegbahn, L. Berglund, P. McKeigue, R. Reneland, and H. Lithell
Plasminogen Activator Inhibitor-1 Activity Is Independently Related to Both Insulin Sensitivity and Serum Triglycerides in 70-Year-Old Men
Arterioscler Thromb Vasc Biol, February 1, 1998; 18(2): 258 - 264.
[Abstract] [Full Text] [PDF]